injections

Integrale SA with the associated capital injections to back them. Moreover, the Company entered into an agreement with AXA Belgium NV for the AXA Portfolio. This transaction is envisaged to complete over the course of September 2022. Over the course of... reporting period from € 14.0m to € 313m. This increase was principally due to the following 3 actions done over the year 2021: ▪ following the acquisition of the Allianz portfolio in April 2021, a capital injection of € 45m was carried out